AMALGAMATED BANK - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 262 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
AMALGAMATED BANK ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$531
-5.7%
34,256
-3.1%
0.01%0.0%
Q1 2024$563
-22.9%
35,344
-18.7%
0.01%
-16.7%
Q4 2023$730
+40.9%
43,449
-2.0%
0.01%
+50.0%
Q3 2023$518
-13.1%
44,3280.0%0.00%
-20.0%
Q2 2023$596
-18.1%
44,328
+1.0%
0.01%
-16.7%
Q1 2023$728
-17.0%
43,880
-6.9%
0.01%
-25.0%
Q4 2022$877
-99.9%
47,136
+2.2%
0.01%
+33.3%
Q3 2022$592,000
+458.5%
46,113
+204.3%
0.01%
+500.0%
Q2 2022$106,000
+9.3%
15,153
+29.6%
0.00%0.0%
Q1 2022$97,000
-43.6%
11,690
-53.8%
0.00%0.0%
Q4 2021$172,000
+149.3%
25,286
+93.8%
0.00%0.0%
Q3 2021$69,000
-11.5%
13,045
-4.3%
0.00%0.0%
Q2 2021$78,000
+11.4%
13,638
-9.7%
0.00%
-66.7%
Q1 2021$70,000
+40.0%
15,1010.0%0.00%
+50.0%
Q4 2020$50,000
+11.1%
15,101
+0.6%
0.00%0.0%
Q3 2020$45,000
-36.6%
15,011
-2.2%
0.00%
-33.3%
Q2 2020$71,000
+7.6%
15,350
-10.2%
0.00%
+50.0%
Q1 2020$66,000
+3.1%
17,103
+0.4%
0.00%
+100.0%
Q4 2019$64,000
-28.9%
17,0350.0%0.00%
-50.0%
Q3 2019$90,000
+36.4%
17,035
-0.7%
0.00%0.0%
Q2 2019$66,000
-14.3%
17,148
+13.6%
0.00%0.0%
Q1 2019$77,000
+175.0%
15,089
+3.4%
0.00%
+100.0%
Q4 2018$28,000
-39.1%
14,590
-2.0%
0.00%0.0%
Q2 2018$46,000
+70.4%
14,892
+29.5%
0.00%0.0%
Q1 2018$27,00011,5020.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Broadfin Capital, LLC 7,097,300$27,750,0004.54%
GREAT POINT PARTNERS LLC 3,817,288$14,926,0002.55%
TANAKA CAPITAL MANAGEMENT INC 256,593$1,003,0002.29%
Consonance Capital Management LP 4,473,607$17,492,0001.58%
Avoro Capital Advisors LLC 3,892,343$15,219,0000.99%
KNOTT DAVID M 380,110$1,486,0000.59%
EAM Investors, LLC 790,872$3,092,0000.55%
Ghost Tree Capital, LLC 550,000$2,151,0000.50%
EAM Global Investors LLC 251,647$984,0000.50%
MANGROVE PARTNERS IM, LLC 924,648$3,615,0000.49%
View complete list of CATALYST PHARMACEUTICALS INC shareholders